Clinical Trial Update: Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing Tebentafusp regimen versus investigator's choice in previously treated advanced melanoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Tebentafusp (tebentafusp)

Snippet

Sponsor: Immunocore Ltd | Conditions: Advanced Melanoma | Phase 3 | Status: RECRUITING